BioCODE

Microclot detection postviral syndromes long COVID

Biocode researches, incubates and commercialises inflammation-centred medical technologies, concentrating specifically on diagnostic solutions that contribute to the management and improvement of human health and wellbeing. Biocode’s expanding brand family currently comprises Biocheck, which focuses on rapid testing, and Biolab, which focuses on diagnostic methodologies.